Search Results for agency_names:"National Institutes of Health"

The National Institute of Allergy and Infectious Diseases (NIAID) will hold a special meeting on February 23, 2021, to review and evaluate grant applications. This meeting will be conducted virtually and is closed to the public to protect confidential information related to trade secrets and personal privacy. Zhuqing (Charlie) Li, Ph.D., will serve as the Scientific Review Officer for this session. The meeting agenda will focus solely on research projects that do not involve clinical trials.

The National Institute of Neurological Disorders and Stroke will hold a meeting of the National Advisory Neurological Disorders and Stroke Council on April 10, 2025, from 1:00 p.m. to 5:00 p.m. This meeting, which will be held virtually, is closed to the public to protect confidential information and personal privacy. The session will focus on reviewing grant applications and discussing future initiatives and other council matters. Interested individuals can submit written comments to the contact person listed in the notice at least 10 days before the meeting.

The National Institutes of Health (NIH) is announcing the availability of a government-owned invention for licensing. This invention involves monoclonal antibodies that can neutralize Epstein-Barr virus (EBV), which causes infectious mononucleosis and various cancers. These antibodies offer potential uses in diagnostics, therapeutics, and vaccine research. Interested parties can contact Peter Soukas for licensing opportunities or collaborative research to further develop and commercialize this technology.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting to discuss grant applications for Digestive Diseases Research Core Centers. The meeting is scheduled for March 27-28, 2025, from 10:00 a.m. to 3:00 p.m. and will be conducted virtually. The discussions will include confidential information, which is why the meeting will not be open to the public. The contact person for more information is Jian Yang, Ph.D.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases is holding closed meetings to review and evaluate grant applications. These meetings are closed to the public due to the confidential nature of the information discussed, which includes trade secrets and personal data. The meetings are scheduled for February 20, 2025, and February 27-28, 2025, and will be conducted virtually. Further details, including contact information for the Scientific Review Officers, are provided in the notice.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 9, 2025, to review and evaluate grant applications. This meeting is closed to the public to protect confidential information, such as trade secrets, patentable material, and personal details of individuals involved. The meeting will take place via video conference, and any inquiries can be directed to Dr. Maryam Rohani, the Scientific Review Officer. This notice adheres to regulations under the Federal Advisory Committee Act.

The National Institute of Mental Health has announced a closed meeting scheduled for April 28, 2025, from 12:00 p.m. to 4:00 p.m., which will be conducted virtually. The meeting is being held to review and evaluate grant applications related to the genetic architecture of mental disorders. This meeting is closed to the public to protect confidential information and personal privacy. For inquiries, Dr. Evon Abisaid is the contact person at the National Institutes of Health.

The National Institute of Diabetes and Digestive and Kidney Diseases will hold a closed virtual meeting on April 28, 2025, from 11:00 a.m. to 1:00 p.m. The purpose of the meeting is to review and evaluate grant applications related to metabolic dysregulation in diabetes. The meeting is closed to the public to protect confidential information and personal privacy. The contact person for the meeting is Elena Sanovich, Ph.D., a Scientific Review Officer at the National Institutes of Health.

The National Institute of General Medical Sciences, part of the National Institutes of Health, announced two upcoming closed meetings on March 3 and March 25, 2021. These meetings are closed to the public because they will involve reviewing grant applications that could reveal confidential information. The March 3 meeting will focus on the National Institute of General Medical Sciences Special Emphasis Panel's review of PRAT Applications, while the March 25 meeting will review the Postdoctoral Research Associate Training (PRAT) Program. The meetings will take place online via video at the NIH campus in Bethesda, Maryland.

In accordance with the Federal Advisory Committee Act, the National Institutes of Health (NIH) announced that several meetings of the Center for Scientific Review will be held virtually. These meetings, taking place between March 19 and March 24, 2021, are closed to the public due to the sensitive nature of the discussions, which include evaluating grant applications and potential disclosure of confidential materials. The subject matter of the meetings ranges from drug discovery and neurodegenerative disorders to HIV/AIDS prevention and treatment, with various scientific review officers assigned to manage the sessions. These sessions aim to review and evaluate various grant proposals, ensuring that personal privacy and proprietary information remain protected.